Popular Articles
Teeth Whitening Products

Vitamin D May Have Key Role In Helping Brain Work Well In Later Life
[Association between 25-hydroxyvitamin D levels and cognitive performance in middle-aged and older European men
generic viagra online
Study Finds People Residing In Poor Communities Not Benefiting From Recent Drop In Colorectal Cancer
A new study suggests that a drop in colorectal cancer incidence seen nationwide has not occurred among people living in poorer communities, and suggests that barriers to health care may be to blame. The study appears online in the journal Cancer Causes and Control.
News of the day
President Obama Picks New York City Health Commissioner Thomas Frieden For CDC Director
President Obama on Friday appointed New York City Health Commissioner Thomas Frieden as CDC director, according to Obama administration officials, the New York Times reports. According to the Times, Frieden, an infectious disease specialist, has "cut a high and sometimes contentious profile" in his seven years as health commissioner in New York City, during which time he has advocated for a smoking ban in restaurants and bars, made HIV testing part of routine medical exams and protected a program that distributes 35 million condoms a year. According to the Times, Frieden is expected to take office next month. The Times reports that he will "inherit a host of immediate and long-term problems," including questions surrounding a vaccine for the H1N1 influenza virus, also known as swine flu, health care reform and organizational issues at CDC.The Times reports that a potential advantage for Frieden is a positive relationship with likely FDA Commissioner Margaret Hamburg, who also was New York City health commissioner. Frieden would work with Hamburg to combat the H1N1 flu virus and to re-evaluate the U.S. food safety system (Harris/Hartocollis, New York Times, 5/15).
Sexual Health

University Of Pittsburgh Cancer Institute Researcher Dr. Merrill Egorin Honored With ASCO Translational Research Professorship

Merrill Egorin, M.D., professor of medicine and pharmacology at the University of Pittsburgh Cancer Institute (UPCI), has received the 2009 American Society of Clinical Oncology (ASCO) Translational Research Professorship for his work in improving cancer treatments and supporting the next generation of researchers. The award provides $100,000 annually for five years to further the training and career development of clinical oncologists for whom translational research is the primary or major component of their professional activities. "I am tremendously honored to receive this wonderful award, which truly encourages bench-to-bedside research," said Dr. Egorin. "I"ve dedicated my career to pursuing translational research and having my efforts recognized by ASCO is both humbling and inspiring." "This award acknowledges Dr. Egorin"s lifelong dedication to improving cancer treatments and rewards his ongoing and passionate commitment to mentoring the next generation of researcher," said Nancy E. Davidson, M.D., director of UPCI and UPMC Cancer Centers. "One of the most important responsibilities for accomplished researchers is the nurturing and support of junior investigators, and no one has been more engaged in this process than Dr. Egorin." Dr. Egorin will use the professorship to continue his pre-clinical and clinical studies of inhibitors of the PARP family of enzymes and how they can be exploited as targets for cancer therapies. PARP enzymes are responsible for a variety of cellular processes, including gene regulation, replication and the maintenance of genomic stability. "The PARP family is an extremely interesting target for drug development. We already have several PARP inhibitors in early development, including several phase I trials evaluating the drug ABT-888. This award will support the expansion of the study of PARP inhibitors in cancer treatments," he said. Dr. Egorin will officially receive his award on May 31 during ASCO"s Grants and Awards ceremony. The University of Pittsburgh Cancer Institute


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):